Earnings call Dr. Lal PathLabs reported Q3 FY26 revenue of ₹660 crore, up 10.6% YoY, supported by a 7.7% rise in revenue per patient. EBITDA margin (pre-exceptional) improved to 27.2%. While patient ...
Dr. Lal Path Labs posts earnings dip on Indian labour code changes; test demand strong Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results